Testing effectiveness (Phase 2)WithdrawnNCT01849887
What this trial is testing
Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke
Who this might be right for
Ischemic Stroke
University of California, Irvine